Wasting in chronic kidney disease
Open Access
- 16 March 2011
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 2 (1), 9-25
- https://doi.org/10.1007/s13539-011-0019-5
Abstract
Wasting/cachexia is prevalent among patients with chronic kidney disease (CKD). It is to be distinguished from malnutrition, which is defined as the consequence of insufficient food intake or an improper diet. Malnutrition is characterized by hunger, which is an adaptive response, whereas anorexia is prevalent in patients with wasting/cachexia. Energy expenditure decreases as a protective mechanism in malnutrition whereas it remains inappropriately high in cachexia/wasting. In malnutrition, fat mass is preferentially lost and lean body mass and muscle mass is preserved. In cachexia/wasting, muscle is wasted and fat is relatively underutilized. Restoring adequate food intake or altering the composition of the diet reverses malnutrition. Nutrition supplementation does not totally reverse cachexia/wasting. The diagnostic criteria of cachexia/protein–energy wasting in CKD are considered. The association of wasting surrogates, such as serum albumin and prealbumin, with mortality is strong making them robust outcome predictors. At the patient level, longevity has consistently been observed in patients with CKD who have more muscle and/or fat, who report better appetite and who eat more. Although inadequate nutritional intake may contribute to wasting or cachexia, recent evidence indicates that other factors, including systemic inflammation, perturbations of appetite‐controlling hormones from reduced renal clearance, aberrant neuropeptide signaling, insulin and insulin‐like growth factor resistance, and metabolic acidosis, may be important in the pathogenesis of CKD‐associated wasting. A number of novel therapeutic approaches, such as ghrelin agonists and melanocortin receptor antagonists are currently at the experimental level and await confirmation by randomized controlled clinical trials in patients with CKD‐associated cachexia/wasting syndrome.Keywords
This publication has 143 references indexed in Scilit:
- The Effect of Resistance Exercise to Augment Long-term Benefits of Intradialytic Oral Nutritional Supplementation in Chronic Hemodialysis PatientsJournal of Renal Nutrition, 2011
- In-Center Hemodialysis Six Times per Week versus Three Times per WeekThe New England Journal of Medicine, 2010
- Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and MuscleJournal of Cachexia, Sarcopenia and Muscle, 2010
- Comparing Body Composition Assessment Tests in Long-term Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2010
- Ghrelin in Chronic Kidney DiseaseInternational Journal of Peptides, 2010
- Oral Protein Supplementation Alone Improves Anabolism in a Dose-Dependent Manner in Chronic Hemodialysis PatientsJournal of Renal Nutrition, 2009
- Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetesKidney International, 2009
- Associates of Mortality and Hospitalization in Hemodialysis: Potentially Actionable Laboratory Variables and Vascular AccessAmerican Journal of Kidney Diseases, 2009
- A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney diseaseKidney International, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004